Alexander Gee | People | Baker McKenzie

Biography

Alexander is a senior associate in the Corporate Group in the London office of Baker McKenzie.

Alexander joined the Firm in March 2010 as a trainee solicitor. Following qualification as a solicitor, Alexander joined the Firm's corporate team in London. Alexander completed a three-month secondment to the Hong Kong office of Baker McKenzie in 2012 and a two-year secondment to Baker McKenzie's Singapore office in 2017. Alexander completed a nine-month client secondment at a UK-based global pharmaceutical group in July 2020.

Practice Focus

Alexander is experienced in domestic and cross-border mergers and acquisitions, with a particular focus on the pharmaceutical, medical devices and healthcare industries, as well as general corporate matters including multi-jurisdictional reorganisations, joint ventures, distressed M&A, and corporate governance issues.

Representative Legal Matters

Advising Coats Group plc on the acquisition of Texon, a leading manufacturer of high-performance sustainable materials for footwear, accessories and functional apparel, from Navis Capital Partners for USD 237 million.

Advising Coats Group plc on the acquisition of Rhenoflex group, a leading global producer of reinforcement solutions for the footwear and accessories industries.

Acting for GSK on the divestment of its rabies and tick-borne encephalitis vaccines to Bavarian Nordic for an upfront payment of approximately EUR 301 million (GBP 259 million) and milestone payments of up to EUR 955 million (GBP 822 million).
Advising Cochlear on its strategic hearing alliance with GN ReSound to develop smart bimodal hearing solutions.
Acting for GSK on the disposal of its API manufacturing site in Cork, Ireland, including all facilities, business operations and approximately 400 commercial manufacturing and R&D employees, for approximately EUR 90 million.
Advising Merck & Co. on its investment in the Vaccines Manufacturing Innovation Centre, a UK Research and Innovation-backed centre for late-stage vaccine manufacturing, research and development.
Acting for GSK on the disposal of its manufacturing facilities in Verona, Italy to ACS Dobfar.
Acted for a global pharmaceutical group on the divestment of its manufacturing facilities in Eastern Europe
Acting for Unilever on its personal care and home care joint venture with Europe & Asia Commercial Co., Ltd. in Myanmar, Unilever EAC Myanmar Company Limited.
Advising a UK-based pharmaceutical company on its private equity investment and the disposal of its Phase I movement disorder drug and related isomers.

Professional Associations and Memberships

Law Society of England and Wales - Member

Admissions

England & Wales~United Kingdom (2012)

Education

College of Law at London (Legal Practice Course) (2009)
Nottingham Trent University (Graduate Diploma in Law) (2008)
University of Nottingham (BA Jt Hons in Classics) (2007)